From: Synthesis and therapeutic potential of imidazole containing compounds
Compounds | MIC (µM/mL) | |||||
---|---|---|---|---|---|---|
S. aureus | B. subtilis | E. coli | C. albicans | A. niger | ||
2a | 0.012 | 0.003 | 0.003 | 0.025 | 0.050 | |
2b | ND | ND | ND | 0.022 | 0.005 | |
2c | ND | ND | ND | 0.005 | 0.005 | |
2d | 0.044 | 0.044 | 0.044 | 0.022 | 0.044 | |
2e | 0.022 | 0.044 | 0.006 | 0.022 | 0.044 | |
2f | 0.044 | 0.044 | 0.011 | 0.342 | 0.044 | |
2g | ND | ND | ND | 0.004 | 0.019 | |
2h | 0.010 | 0.010 | 0.040 | 0.020 | 0.040 | |
2i | 0.040 | 0.002 | 0.040 | 0.020 | 0.040 | |
2j | 0.013 | 0.005 | 0.002 | 0.025 | 0.025 | |
2k | 0.002 | 0.002 | 0.002 | 0.020 | 0.040 | |
Ciprofloxacin | 0.004 | 0.004 | 0.004 | – | – | |
Fluconazole | – | – | – | 0.005 | 0.005 |